Headline
The latest stories from AHA Today.
The Food and Drug Administration today awarded a contract to the National Academies of Sciences, Engineering, and Medicine to develop evidence-based guidelines for appropriate opioid analgesic prescribing for acute pain resulting from specific conditions or procedures.
In 2016, the difference between the amount that the Medicare drug benefit program reported spending on 29 brand-name combination medications and the estimated spending for generic constituents for the same number of doses was $925 million.
The National Human Trafficking Training and Technical Assistance Center Sept. 5 at 1 p.m. ET will host a webinar highlighting emerging trends, case studies and best practices for providing supportive services to individuals with disabilities who are at risk or currently experiencing human…
The Hospital Council of Northern and Central California has selected Bryan Bucklew as its new president and CEO. Bucklew has led the Greater Dayton Area Hospital Association in Ohio since 2005.
Hospitals, health systems and health care organizations can register today to participate as a host site for the Institute for Diversity and Health Equity’s Fall Enrichment Program.
The Centers for Medicare & Medicaid Services today awarded $8.6 million to 30 states and the District of Columbia to provide state insurance regulators with the opportunity to enhance states’ ability to strengthen their health insurance markets through innovative measures.
The Food and Drug Administration Aug. 17 issued a safety alert after reviewing the final results from a post-approval study conducted by SynCardia Systems for their Temporary Total Artificial Heart (TAH-t) Companion 2 Driver System.
Clinicians can apply through Sept. 6 to participate in the Centers for Medicare & Medicaid Services' Medicare Advantage Qualifying Incentive Arrangement Demonstration.
The Drug Enforcement Administration today issued its proposed 2019 aggregate production quotas for certain controlled substances, which the agency said would reduce manufacturing quotas for six frequently misused opioids by an average 10 percent.
The Centers for Medicare & Medicaid Services has approved DNV GL – Healthcare for continued recognition as a national accrediting organization for hospitals that wish to participate in the Medicare and Medicaid programs.